.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Inflammatory bone defects significantly impact human health, especially when traditional stem cell therapies struggle against high oxidative stress. Recent breakthroughs in chiral nanozymes bone regeneration highlight the potential of metal-organic framework (MOF) nanozymes. Researchers inspired by deep-sea lobster hemocyanin have developed bionic Cu-Phe (D/L) nanozymes that effectively regulate the intracellular antioxidant defense system.
The study utilized a chiral engineering strategy to prepare Cu-Phe nanozymes using right-handed (D) and left-handed (L) phenylalanine ligands. Furthermore, the researchers observed that the Cu-Phe (L) variant clears reactive oxygen species (ROS) with remarkable efficiency. Consequently, this clearing of ROS protects cellular functionality and facilitates a shift in macrophage phenotype. Therefore, these nanozymes create a favorable environment for stem cell growth and tissue repair.
Moreover, the bionic nanozymes mimic natural superoxide dismutase (SOD) and catalase (CAT) activities. By reshaping the oxidative stress microenvironment, the Cu-Phe (L) nanozymes enhance osteoimmunomodulation. Specifically, they promote the differentiation of stem cells into bone-forming cells. Thus, this technology provides a rational roadmap for treating complex inflammatory bone defects using biomimetic materials.
Chiral nanozymes modulate oxidative stress by mimicking natural enzymes. Specifically, the left-handed Cu-Phe (L) variant effectively removes harmful reactive oxygen species, thereby allowing stem cells to differentiate into bone tissue more efficiently.
These nanozymes offer a targeted approach to treating bone defects characterized by chronic inflammation. Furthermore, they provide a more stable and effective alternative to traditional therapies in high-stress microenvironments.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers developed chiral Cu-Phe nanozymes that mimic lobster hemocyanin to clear ROS and promote osteogenic differentiation in inflammatory bone defects...
5 months ago
Metabolic dysfunction-associated fatty liver disease (MAFLD) involves severe lipid accumulation in hepatocytes. Recent research reveals that the microbial metabolite indole-3-propionic acid (IPA) activates the AHR/AMPK pathway, significantly reducing lipid synthesis and mitigating hepatic steatosis.
Today
A multicenter study identifies a three-metabolite gut microbiota panel (3-hydroxydecanoic acid, γ-Glu-Leu, and propionic acid) for early risk stratification of gestational diabetes mellitus in the first trimester, offering superior predictive accuracy over standard clinical risk factors before 24 weeks.
Today
A cross-sectional analysis from the Electronic Framingham Heart Study reveals that a higher daily heart rate per step ratio is associated with lower composite cognitive scores in older adults, highlighting smartwatch metrics as valuable tools for detecting subclinical cardiovascular factors linked to brain health.
Today
A cadaveric study compares the biomechanical strength, load-to-failure, and stiffness of tape-augmented all-soft tissue quadriceps tendon autografts against quadrupled semitendinosus constructs in ACL reconstruction, providing crucial insights for orthopaedic surgeons regarding graft selection and fixation.
Today
Discover clinical pitfalls in diagnosing SGLT2 inhibitor ketoacidosis in the ICU. Learn how cardiac surgery and GLP-1 agonist interactions trigger euglycemic DKA and explore management strategies.
Yesterday
